CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates Ejection Fraction Pros and Cons: JACC State-of-the-Art Review In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure) Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

Review Articlev.10(8); 2021 Aug

JOURNAL:Cells. Article Link

Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis

W Masson, A Lavalle-Cobo, JP Nogueira et al. Keywords: SGLT2-i; epicardial adipose tissue

Full Text PDF